Facebook Reiterated at Outperform and 4 Reiterated Ratings Demanding Attention

Stock upgrades and downgrades are a controversial part of Wall Street. Despite regulations, many banks and firms still have a positive bias toward current clients and companies desired as future clients. In addition, Wall Street analysts are straight-up biased to the buy side. The percentage of sell recommendations is normally below 15 percent!

Regardless, upgrades and downgrades move stocks in the short-term. They fall into our CHEAT SHEET framework category ‘C = Catalyst for a Stock’s Movement’. Here are catalysts you must know today:

Facebook (NASDAQ:FB): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $27 to $34.

Current Price $31.3599

FB

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

Celgene (NASDAQ:CELG): Cantor Fitzgerald reiterated its rating of Buy for this company and changed its price target from $96 to $115.

Current Price $96.94

CELG

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

Marriott (NYSE:MAR): Cantor Fitzgerald reiterated its rating of Buy for this company and changed its price target from $44 to $48.

Current Price $38.81

MAR

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

Madison Square Garden (NASDAQ:MSG): Needham reiterated its rating of Buy for this company and changed its price target from $44 to $55.

Current Price $47.0103

MSG

Dexcom (NASDAQ:DXCM): Wunderlich reiterated its rating of Buy for this company and changed its price target from $15 to $18.

Current Price $14.64

DXCM

Don’t Miss: What’s Next for Facebook?